{"id":63292,"date":"2025-02-22T09:34:56","date_gmt":"2025-02-22T14:34:56","guid":{"rendered":"https:\/\/www.businessupturn.com\/usa\/?p=63292"},"modified":"2025-02-22T09:34:56","modified_gmt":"2025-02-22T14:34:56","slug":"stock-summary-hims-hers-health-witnessed-weekly-fall-of-18-22","status":"publish","type":"post","link":"https:\/\/www.businessupturn.com\/usa\/stock-summary-hims-hers-health-witnessed-weekly-fall-of-18-22\/63292\/","title":{"rendered":"Stock summary: Hims & Hers Health witnessed weekly fall of 18.22%"},"content":{"rendered":"<p><span style=\"font-weight: 400\">In the healthcare sector <\/span><b>Hims & Hers Health Inc<\/b><span style=\"font-weight: 400\"> stock closed at <\/span><b>49.28 USD<\/b><span style=\"font-weight: 400\">, recording a sharp decline of <\/span><b>10.98 USD (-18.22%)<\/b><span style=\"font-weight: 400\"> over the past five days. This significant drop came after the US FDA announced that Ozempic, Wegovy shortages have come to an end. However, in the initial half of the week, the healthcare stock surged after the company revealed that it has acquired at-home lab testing provider Sigmund, or Trybe Labs, to allow the company to offer at-home blood testing<\/span><\/p>\n<p><span style=\"font-weight: 400\">On <\/span><b>February 21 at 7:59 PM GMT-5<\/b><span style=\"font-weight: 400\">, the stock saw a wide trading range, reaching a high of <\/span><b>57.37 USD<\/b><span style=\"font-weight: 400\"> and a low of <\/span><b>49.05 USD<\/b><span style=\"font-weight: 400\"> during the session. The stock opened at <\/span><b>53.51 USD<\/b><span style=\"font-weight: 400\">. In after-hours trading, the stock slipped further by <\/span><b>0.28 USD (0.57%)<\/b><span style=\"font-weight: 400\">, bringing its price to <\/span><b>49.00 USD<\/b><span style=\"font-weight: 400\">, indicating continued caution among investors.<\/span><\/p>\n<p><span style=\"font-weight: 400\">With a <\/span><b>market capitalization of 1.08KCr<\/b><span style=\"font-weight: 400\">, Hims & Hers Health continues to retain its position in the healthcare sector.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Disclaimer: This article is for informational purposes only and does not constitute any financial advice. <\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In the healthcare sector Hims & Hers Health Inc stock closed at 49.28 USD, recording a sharp decline of 10.98 USD (-18.22%) over the past five days.<\/p>\n","protected":false},"author":433,"featured_media":61635,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[73],"tags":[19404],"class_list":["post-63292","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-us-markets","tag-hims-hers-health"],"reading_time":"1 min read","_links":{"self":[{"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/posts\/63292","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/users\/433"}],"replies":[{"embeddable":true,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/comments?post=63292"}],"version-history":[{"count":0,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/posts\/63292\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/media\/61635"}],"wp:attachment":[{"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/media?parent=63292"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/categories?post=63292"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/tags?post=63292"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}